SCHEMBL5710568

SCHEMBL5710568

C#CCN(CC)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4621524 0.85 PYCR1 (0.35)
SCHEMBL12073330 0.81
SCHEMBL2705472 0.79
SCHEMBL22858694 0.79 LMNA (0.39)
SCHEMBL11379681 0.79
SCHEMBL537444 0.79 CA12 (0.45)
SCHEMBL42300 0.76
SCHEMBL5406160 0.76
SCHEMBL11740017 0.76 DPP4 (0.37)
SCHEMBL19379185 0.76 PYCR1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448195-B1 N-ADAMANTYLMETHYL DERIVATES AND INTERMEDIATES AS PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PREPARATION ASTRAZENECA AB (SE) 2006-11-02 EP disclosed
US-7129246-B2 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation ASTRAZENECA AB (SE) 2006-10-31 US disclosed
US-20050010052-A1 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation ASTRAZENECA AB (SE) 2005-01-13 US disclosed
EP-1448195-A1 N-ADAMANTYLMETHYL DERIVATES AND INTERMEDIATES AS PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PREPARATION AstraZeneca AB (SE) 2004-08-25 EP disclosed
WO-2003041707-A1 N-ADAMANTYLMETHYL DERIVATES AND INTERMEDIATES AS PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PREPARATION ASTRAZENECA AB (SE) 2003-05-22 WO disclosed